Among them, triple-negative breast cancer (TNBC) is a particularly aggressive subtype of breast cancer, defined by the lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast cancer.